STOCK TITAN

Almaden updates arbitration timing and grants stock options

Almaden Minerals Ltd. reports developments in its international arbitration claim under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) against the United Mexican States.

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Almaden Minerals Ltd. reports developments in its international arbitration claim under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) against the United Mexican States. The Tribunal has rescheduled the hearing from December 2026 to July 2027, extending its length from six to up to ten days to allow additional time for examination of fact witnesses and experts.

The company also confirms shareholder approval and renewal of its shareholder rights plan at the annual general and special meeting held on June 25, 2026. In addition, under its Stock Option Plan, Almaden granted a director options to purchase 800,000 common shares at an exercise price of $0.27 per share, expiring on August 13, 2031. The news release includes standard cautionary language regarding forward-looking statements related to the arbitration process and associated risks and assumptions.

Positive

  • None.

Negative

  • None.

Filing Explained

The filing identifies the arbitration’s claimant structure: Almaden and Almadex are pursuing it for themselves and their Mexican subsidiaries; before the reported loss of the investment, Almaden held 100% of the Ixtaca project and Almadex held a 2.0% NSR royalty.

Arbitration hearing timing July 2027 Rescheduled CPTPP arbitration hearing with Mexico from December 2026 to July 2027
Hearing duration up to ten days Hearing extended from six to up to ten days to examine witnesses and experts
Shareholder meeting date June 25, 2026 Date shareholders approved renewal of the shareholder rights plan
Stock options granted 800,000 common shares Options granted to a director under the Stock Option Plan
Option exercise price $0.27 per share Exercise price for the 800,000 stock options granted to a director
Option expiry date August 13, 2031 Expiry date of the 800,000 stock options granted to a director
shareholder rights plan financial
"The Company further announces the renewal of its shareholder rights plan, as approved"
A shareholder rights plan is a board-approved defense that makes an unsolicited takeover harder by triggering measures—such as issuing extra shares or special rights—if one investor accumulates a large stake without board approval. Think of it as a temporary roadblock that protects existing management and gives the company time to seek better offers. It matters to investors because it can affect share price, takeover chances, and whether a competing buyer can quickly buy control.
Stock Option Plan financial
"In addition, pursuant to its Stock Option Plan, the Company has granted stock options"
A stock option plan is a company program that gives employees the right to buy company shares at a preset price after a certain time, like a coupon allowing purchase later at a fixed rate. It matters to investors because these options can increase the number of shares outstanding — reducing each existing share’s ownership slice and potentially changing per-share results — while also aligning employee incentives with boosting the company’s value.
forward-looking statements regulatory
"Certain of the statements and information in this news release constitute “forward-looking statements”"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Comprehensive and Progressive Agreement for Trans-Pacific Partnership regulatory
"proceedings (the “Claim”) under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership"

FAQ

What arbitration update did Almaden Minerals (AAUAF) disclose in August 2026?

Almaden reported that the Tribunal rescheduled its CPTPP arbitration hearing with Mexico from December 2026 to July 2027, extending the hearing from six to up to ten days to allow more time for examining witnesses and experts.

When is Almaden Minerals’ CPTPP arbitration hearing with Mexico now scheduled?

The Tribunal has rescheduled Almaden’s CPTPP arbitration hearing with Mexico to July 2027. The hearing length was also increased from six to up to ten days to permit fuller examination of fact and expert witnesses.

What did Almaden Minerals (AAUAF) say about its shareholder rights plan?

Almaden stated that its shareholder rights plan was renewed, following approval by shareholders at the annual general and special meeting held on June 25, 2026. The renewal is intended to continue the existing rights plan framework for shareholders.

What stock options were granted by Almaden Minerals in this 6-K?

Almaden granted a director options to purchase 800,000 common shares under its Stock Option Plan. The options carry an exercise price of $0.27 per share and have an expiry date of August 13, 2031, providing long-term equity-based compensation.

What risks did Almaden Minerals highlight in its forward-looking statements?

Almaden highlighted risks related to the CPTPP application, political and legal conditions in Mexico, crime and corruption, the uncertain arbitration outcome, and potential limits on funding the arbitration, along with other risks referenced in its Annual Information Form and latest Form 20-F.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2026

Commission File Number: 001-32702

Almaden Minerals Ltd.
(Translation of registrant's name into English)

Suite 210 - 1333 Johnston Street, Vancouver V6H 3R9
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Almaden Minerals Ltd.    
  (Registrant)
   
  
Date: August 14, 2026     /s/ DOUGLAS MCDONALD    
  Douglas McDonald
  President & CEO
  


EXHIBIT INDEX 

Exhibit Number Description
   
99.1 Press Release dated August 14, 2026

EXHIBIT 99.1

Almaden Provides Update on Arbitration Process with Mexico

Hearing Date Rescheduled

VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSXV: AMM; OTCQB: AAUAF) provides an update on the international arbitration proceedings (the “Claim”) under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) with the United Mexican States (“Mexico”).

Almaden is pursuing this Claim together with Almadex Minerals Ltd. (“Almadex”), on behalf of themselves and their Mexican subsidiaries (the “Claimants”). Prior to the illegal acts of Mexico which resulted in the complete loss of the investment, Almaden held 100% of the Ixtaca precious metals project in Mexico (the “Project”), while Almadex held a 2.0% NSR royalty on the Project.

The Claimants have been informed by the Tribunal that the dates for the hearing have been rescheduled from December, 2026, to July, 2027. The purpose of the delay is to extend the hearing from six to up to ten days, so as to provide sufficient time for examination of all fact witnesses and experts. The new dates in July are the first that the Tribunal can accommodate.

While the Company is disappointed by the delay, it is encouraged that the additional time will enable better presentation of its case.

The Company further announces the renewal of its shareholder rights plan, as approved by shareholders at the Company’s last annual general and special meeting held on June 25, 2026.

In addition, pursuant to its Stock Option Plan, the Company has granted stock options to a director of the Company to purchase an aggregate 800,000 common shares in the capital of the Company at an exercise price of $0.27 per share expiring on August 13, 2031.

On behalf of the Board of Directors,

“Douglas J. McDonald”
Douglas J. McDonald, B.Com, M.A.Sc.
President & CEO
Almaden Minerals Ltd.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Safe Harbor Statement

Certain of the statements and information in this news release constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian provincial securities laws. All statements, other than statements of historical fact, are forward-looking statements or information. Forward-looking statements or information in this news release relate to, among other things, the Company’s presentation of its case at the hearings.

These forward-looking statements and information reflect the Company’s current views with respect to future events and are necessarily based upon a number of assumptions that, while considered reasonable by the Company, are inherently subject to significant legal, regulatory, business, operational and economic uncertainties and contingencies, and such uncertainty generally increases with longer-term forecasts and outlook. These assumptions include: stability and predictability in Mexico’s response to the arbitration process under the CPTPP; stability and predictability in the application of the CPTPP and arbitral decisions thereon; the ability to continue to finance the arbitration process, and continued respect for the rule of law in Mexico. The foregoing list of assumptions is not exhaustive.

The Company cautions the reader that forward-looking statements and information involve known and unknown risks, uncertainties and other factors that may cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements or information contained in this news release. Such risks and other factors include, among others, risks related to: the application of the CPTPP and arbitral decisions thereon; continued respect for the rule of law in Mexico; political risk in Mexico; crime and violence in Mexico; corruption in Mexico; uncertainty as to the outcome of arbitration or the funding available to the Company to pursue it; as well as those factors discussed the section entitled "Risk Factors" in Almaden's Annual Information Form and Almaden's latest Form 20-F on file with the United States Securities and Exchange Commission in Washington, D.C. Although the Company has attempted to identify important factors that could affect the Company and may cause actual actions, events or results to differ materially from those described in forward-looking statements or information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that our forward-looking statements or information will prove to be accurate. Accordingly, readers should not place undue reliance on forward-looking statements or information. Except as required by law, the Company does not assume any obligation to release publicly any revisions to on forward-looking statements or information contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information:

Almaden Minerals Ltd.
Tel. 604.689.7644
Email: info@almadenminerals.com
http://www.almadenminerals.com/

Filing Exhibits & Attachments

1 document